(1-acetyloxy-3-hexadecanoyloxypropan-2-yl) (8E,11E,14E,17E)-icosa-8,11,14,17-tetraenoate

C41H70O6 — CID 11621640

IUPAC(1-acetyloxy-3-hexadecanoyloxypropan-2-yl) (8E,11E,14E,17E)-icosa-8,11,14,17-tetraenoate
SMILESCC/C=C/C/C=C/C/C=C/C/C=C/CCCCCCC(=O)OC(COC(C)=O)COC(=O)CCCCCCCCCCCCCCC
InChIInChI=1S/C41H70O6/c1-4-6-8-10-12-14-16-18-19-20-21-23-25-27-29-31-33-35-41(44)47-39(36-45-38(3)42)37-46-40(43)34-32-30-28-26-24-22-17-15-13-11-9-7-5-2/h6,8,12,14,18-19,21,23,39H,4-5,7,9-11,13,15-17,20,22,24-37H2,1-3H3/b8-6+,14-12+,19-18+,23-21+
InChIKeyQEHNGQLLFMEKNW-ALNOKNKVSA-N
MW659.01 g/mol
LogP11.63
Rot. Bonds33

About (1-acetyloxy-3-hexadecanoyloxypropan-2-yl) (8E,11E,14E,17E)-icosa-8,11,14,17-tetraenoate

(1-acetyloxy-3-hexadecanoyloxypropan-2-yl) (8E,11E,14E,17E)-icosa-8,11,14,17-tetraenoate (PubChem CID 11621640) has the molecular formula C41H70O6 and a molecular weight of 659.01 g/mol. Its IUPAC name is (1-acetyloxy-3-hexadecanoyloxypropan-2-yl) (8E,11E,14E,17E)-icosa-8,11,14,17-tetraenoate.

Molecular Properties

Compound Name(1-acetyloxy-3-hexadecanoyloxypropan-2-yl) (8E,11E,14E,17E)-icosa-8,11,14,17-tetraenoate
PubChem CID11621640
Molecular FormulaC41H70O6
Molecular Weight659.01 g/mol
Exact Mass658.52
IUPAC Name(1-acetyloxy-3-hexadecanoyloxypropan-2-yl) (8E,11E,14E,17E)-icosa-8,11,14,17-tetraenoate
SMILESCC/C=C/C/C=C/C/C=C/C/C=C/CCCCCCC(=O)OC(COC(C)=O)COC(=O)CCCCCCCCCCCCCCC
InChIInChI=1S/C41H70O6/c1-4-6-8-10-12-14-16-18-19-20-21-23-25-27-29-31-33-35-41(44)47-39(36-45-38(3)42)37-46-40(43)34-32-30-28-26-24-22-17-15-13-11-9-7-5-2/h6,8,12,14,18-19,21,23,39H,4-5,7,9-11,13,15-17,20,22,24-37H2,1-3H3/b8-6+,14-12+,19-18+,23-21+
InChIKeyQEHNGQLLFMEKNW-ALNOKNKVSA-N
XLogP11.63
TPSA78.90 Ų
H-Bond Donors
H-Bond Acceptors6
Rotatable Bonds33
Heavy Atoms47
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500659.01
LogP ≤ 511.63
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze (1-acetyloxy-3-hexadecanoyloxypropan-2-yl) (8E,11E,14E,17E)-icosa-8,11,14,17-tetraenoate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (1-acetyloxy-3-hexadecanoyloxypropan-2-yl) (8E,11E,14E,17E)-icosa-8,11,14,17-tetraenoate?
The IUPAC name of (1-acetyloxy-3-hexadecanoyloxypropan-2-yl) (8E,11E,14E,17E)-icosa-8,11,14,17-tetraenoate (CID 11621640) is (1-acetyloxy-3-hexadecanoyloxypropan-2-yl) (8E,11E,14E,17E)-icosa-8,11,14,17-tetraenoate.
What is the SMILES notation for (1-acetyloxy-3-hexadecanoyloxypropan-2-yl) (8E,11E,14E,17E)-icosa-8,11,14,17-tetraenoate?
The canonical SMILES for (1-acetyloxy-3-hexadecanoyloxypropan-2-yl) (8E,11E,14E,17E)-icosa-8,11,14,17-tetraenoate is CC/C=C/C/C=C/C/C=C/C/C=C/CCCCCCC(=O)OC(COC(C)=O)COC(=O)CCCCCCCCCCCCCCC.
What is the InChIKey of (1-acetyloxy-3-hexadecanoyloxypropan-2-yl) (8E,11E,14E,17E)-icosa-8,11,14,17-tetraenoate?
The InChIKey is QEHNGQLLFMEKNW-ALNOKNKVSA-N. The full InChI is InChI=1S/C41H70O6/c1-4-6-8-10-12-14-16-18-19-20-21-23-25-27-29-31-33-35-41(44)47-39(36-45-38(3)42)37-46-40(43)34-32-30-28-26-24-22-17-15-13-11-9-7-5-2/h6,8,12,14,18-19,21,23,39H,4-5,7,9-11,13,15-17,20,22,24-37H2,1-3H3/b8-6+,14-12+,19-18+,23-21+.
What are the key properties of (1-acetyloxy-3-hexadecanoyloxypropan-2-yl) (8E,11E,14E,17E)-icosa-8,11,14,17-tetraenoate?
(1-acetyloxy-3-hexadecanoyloxypropan-2-yl) (8E,11E,14E,17E)-icosa-8,11,14,17-tetraenoate has a molecular weight of 659.01 g/mol, XLogP of 11.63, 33 rotatable bonds, 0 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for (1-acetyloxy-3-hexadecanoyloxypropan-2-yl) (8E,11E,14E,17E)-icosa-8,11,14,17-tetraenoate is sourced from PubChem (CID 11621640), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).